Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine